Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Hoertel

Showing results (161-170 of 169) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 169 results.
Journal of Affective Disorders|March 25, 2019
Subsyndromal and syndromal depressive symptoms among older adults with schizophrenia spectrum disorder: Prevalence and associated factors in a multicenter studyNicolas Hoertel, Claire Jaffré, Rachel Pascal de Raykeer, et al.
Clinical Pharmacology and Therapeutics|May 29, 2021
Association Between FIASMAs and Reduced Risk of Intubation or Death in Individuals Hospitalized for Severe COVID-19: An Observational Multicenter StudyNicolas Hoertel, Marina Sánchez-Rico, Erich Gulbins, et al.
Molecular Psychiatry|March 3, 2023
Association of fluvoxamine with mortality and symptom resolution among inpatients with COVID-19 in Uganda: a prospective interventional open-label cohort studyBruce J Kirenga, Levicatus Mugenyi, Marina Sánchez-Rico, et al.
Viruses|April 27, 2024
Fluoxetine and Sertraline Potently Neutralize the Replication of Distinct SARS-CoV-2 VariantsLaura Thümmler, Nadine Beckmann, Carolin Sehl, et al.
Biological Psychiatry Global Open Science|January 11, 2022
Risk of Death in Individuals Hospitalized for COVID-19 With and Without Psychiatric Disorders: An Observational Multicenter Study in FranceNicolas Hoertel, Marina Sánchez-Rico, Pedro de la Muela, et al.
International Journal of Molecular Sciences|November 11, 2022
Antiviral and Anti-Inflammatory Activities of Fluoxetine in a SARS-CoV-2 Infection Mouse ModelDavid Péricat, Stephen Adonai Leon-Icaza, Marina Sanchez Rico, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2023
Medications Modulating the Acid Sphingomyelinase/Ceramide System and 28-Day Mortality among Patients with SARS-CoV-2: An Observational StudyNicolas Hoertel, Katayoun Rezaei, Marina Sánchez-Rico, et al.
Journal of Clinical Medicine|December 24, 2021
Hydroxyzine Use and Mortality in Patients Hospitalized for COVID-19: A Multicenter Observational StudyMarina Sánchez-Rico, Frédéric Limosin, Raphaël Vernet, et al.
Journal of Clinical Medicine|October 14, 2022
Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19Nicolas Hoertel, Marina Sánchez-Rico, Johannes Kornhuber, et al.
Pageof 17

Showing results (161-170 of 169) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 169 results.
Journal of Affective Disorders|March 25, 2019
Subsyndromal and syndromal depressive symptoms among older adults with schizophrenia spectrum disorder: Prevalence and associated factors in a multicenter studyNicolas Hoertel, Claire Jaffré, Rachel Pascal de Raykeer, et al.
Clinical Pharmacology and Therapeutics|May 29, 2021
Association Between FIASMAs and Reduced Risk of Intubation or Death in Individuals Hospitalized for Severe COVID-19: An Observational Multicenter StudyNicolas Hoertel, Marina Sánchez-Rico, Erich Gulbins, et al.
Molecular Psychiatry|March 3, 2023
Association of fluvoxamine with mortality and symptom resolution among inpatients with COVID-19 in Uganda: a prospective interventional open-label cohort studyBruce J Kirenga, Levicatus Mugenyi, Marina Sánchez-Rico, et al.
Viruses|April 27, 2024
Fluoxetine and Sertraline Potently Neutralize the Replication of Distinct SARS-CoV-2 VariantsLaura Thümmler, Nadine Beckmann, Carolin Sehl, et al.
Biological Psychiatry Global Open Science|January 11, 2022
Risk of Death in Individuals Hospitalized for COVID-19 With and Without Psychiatric Disorders: An Observational Multicenter Study in FranceNicolas Hoertel, Marina Sánchez-Rico, Pedro de la Muela, et al.
International Journal of Molecular Sciences|November 11, 2022
Antiviral and Anti-Inflammatory Activities of Fluoxetine in a SARS-CoV-2 Infection Mouse ModelDavid Péricat, Stephen Adonai Leon-Icaza, Marina Sanchez Rico, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2023
Medications Modulating the Acid Sphingomyelinase/Ceramide System and 28-Day Mortality among Patients with SARS-CoV-2: An Observational StudyNicolas Hoertel, Katayoun Rezaei, Marina Sánchez-Rico, et al.
Journal of Clinical Medicine|December 24, 2021
Hydroxyzine Use and Mortality in Patients Hospitalized for COVID-19: A Multicenter Observational StudyMarina Sánchez-Rico, Frédéric Limosin, Raphaël Vernet, et al.
Journal of Clinical Medicine|October 14, 2022
Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19Nicolas Hoertel, Marina Sánchez-Rico, Johannes Kornhuber, et al.
Pageof 17